CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Agreement ended · Results of operations · Other events
- 144 Insider Sale of Securities
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Other events
- UPLOAD Other SEC-generated Letter
- 8-K Event Agreement ended · Other events
- 4 Open-market sale Chief Financial Officer sold 472 shares at $179.55 ($84,747)
- 144 Insider Sale of Securities
- 4 Open-market sale Global Head of R&D sold 1,108 shares at an average $181.92 ($201,567)
- 4 Open-market sale Chief Financial Officer sold 840 shares at $182.85 ($153,594)
- 4 Planned sale Director sold 578 shares at an average $182.32 ($105,381)
- 4 Open-market sale President, COO & GM China sold 1,495 shares at $182.37 ($272,636)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Grant or award Director acquired 12,922 shares (grant or award)
- 4 Grant or award Director acquired 12,922 shares (grant or award)
- 4 Grant or award Director acquired 12,922 shares (grant or award)
Page 24 of 64 · 1,278 filings